J Cell Physiol (2010) 224(2):51626
When patients lose a substantial amount of weight on GLP-1s, they experience volume loss in these facial fat pads and appear sunken in, often looking older than their actual age
Starting at subtherapeutic doses (microdosing protocols) or using compounded formulations with customized titration steps may help patients build tolerance before advancing to standard maintenance doses
Pharma Industry 3 min read WHO backs GLP-1 treatments to tackle obesity epidemic On Monday, the United Nations health agency issued its first guidelines on how such drugs could be used as a key tool for treating obesity in adults as a chronic, relapsing disease
The branded shake offers convenience but likely provides no advantage over regular protein powder plus a multivitamin from a physiological perspective
The weight loss pattern continued, and participants lost an average of 14.9% of their body weight after 68 weeks